Finerenone: A Novel Drug Discovery for the Treatment of Chronic Kidney Disease

CONCLUSION: The present review covers the complete picture of ADME properties, bioanalytical techniques, clinical trials, toxicity, and possible avenues in this arena. Finerenone is effective compared to other mineralocorticoid receptor-like spironolactone and eplerenone, for the treatment of chronic kidney disease.PMID:38288821 | DOI:10.2174/0115701638283354240103115420

Source: Current Drug Discovery Technologies - January 30, 2024 Category: Drugs & Pharmacology Authors: Akshita Rana Jagdish K Sahu Source Type: research